4887:TSESAWAI GROUP HOLDINGS Co., Ltd. Analysis
Data as of 2026-03-15 - not real-time
¥2,127.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Sawai Group is trading at ¥2,127, which sits below its 20‑day (¥2,265.7) and 50‑day (¥2,339.2) moving averages, indicating short‑term weakness, yet it remains above the 200‑day average (¥2,043.3), suggesting a neutral longer trend. Technical signals are mixed: the RSI of 31 points to oversold conditions and a potential bounce near the identified support level of ¥2,085, while a bearish MACD histogram reinforces downside pressure. On the valuation side, the trailing P/E of 21.98 is comfortably under the industry average of 26.18, and a forward P/E of 12.43 hints at earnings acceleration, but a discounted cash‑flow model flags a fair value around ¥1,103, implying the market may be pricing in a significant premium. Fundamentally, the company delivers a 2.59% dividend yield with a 55% payout ratio, supported by ample cash reserves (¥46.6 bn) despite a high debt load (¥122.5 bn) and a debt‑to‑equity ratio of 68.5, which raises concerns about leverage and sustainability. Recent Q3 earnings call material did not reveal major surprises, and the stock’s volatility of 25.6% over 30 days combined with a low beta of 0.16 suggests price swings are largely company‑specific rather than market‑driven. Overall, the blend of modest valuation upside, attractive dividend, and elevated financial risk creates a nuanced investment case.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support at ¥2,085
- Oversold RSI suggesting limited downside
- Bearish MACD indicating continued pressure
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Trailing P/E below industry average
- Forward P/E of 12.4 implying earnings growth
- Attractive 2.59% dividend yield with moderate payout
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High debt‑to‑equity ratio and negative free cash flow
- DCF fair value far below current price
- Stable sector demand offset by regulatory and leverage risks
Key Metrics & Analysis
Financial Health
Revenue Growth1.20%
Profit Margin4.10%
P/E Ratio22.0
ROE-0.67%
ROA2.59%
Debt/Equity68.51
P/B Ratio1.4
Op. Cash Flow¥20.3B
Free Cash Flow¥-1034124992
Industry P/E26.2
Technical Analysis
TrendNeutral
RSI31.2
Support¥2,085.00
Resistance¥2,407.00
MA 20¥2,265.70
MA 50¥2,339.19
MA 200¥2,043.30
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair Value¥1,102.97
Target Price¥2,666.67
Upside/Downside25.37%
GradeFair
TypeBlend
Dividend Yield2.59%
Risk Assessment
Beta0.17
Volatility25.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.